Ricardo Morilla
- Genetics top 0.2%
- Pathology and Forensic Medicine top 0.2%
- Immunology top 1%
- Hematology top 0.5%
- Oncology top 5%
- Co-authors
- Estella MatutesDaniel CatovskyK Owusu-AnkomahD CatovskyNahla FarahatE MatutesJohn SwansburyMassimo De Martinis
- Topics
- Chronic Lymphocytic Leukemia Research (48 papers)Lymphoma Diagnosis and Treatment (33 papers)Acute Myeloid Leukemia Research (21 papers)
- Partner nations
- United KingdomSpainSwitzerland
In The Last Decade
Ricardo Morilla
92 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Genetics 2.5k
- Pathology and Forensic Medicine 2.2k
- Immunology 1.8k
- Hematology 1.4k
- Oncology 940
Countries citing papers authored by Ricardo Morilla
This map shows the geographic impact of Ricardo Morilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Morilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Morilla more than expected).
Fields of papers citing papers by Ricardo Morilla
This network shows the impact of papers produced by Ricardo Morilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Morilla. The network helps show where Ricardo Morilla may publish in the future.
Co-authorship network of co-authors of Ricardo Morilla
This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Morilla. A scholar is included among the top collaborators of Ricardo Morilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Morilla. Ricardo Morilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 64 | |
| 3 | 5 | |
| 4 | 32 | |
| 5 | Report of the European Myeloma Network (EMN) workshop on multiparametric flow cytometry in multiple myeloma and related disorders | 0 |
| 6 | 1 | |
| 7 | 34 | |
| 8 | 21 | |
| 9 | 15 | |
| 10 | 54 | |
| 11 | 56 | |
| 12 | 23 | |
| 13 | Differential TdT expression in acute leukemia by flow cytometry: a quantitative study. | 13 |
| 14 | 62 | |
| 15 | 10 | |
| 16 | 152 | |
| 17 | 3 | |
| 18 | 15 | |
| 19 | 26 | |
| 20 | 58 |
About Ricardo Morilla
Ricardo Morilla is a scholar working on Genetics, Hematology and Immunology, having authored 93 papers that have together received 4.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (48 papers), Lymphoma Diagnosis and Treatment (33 papers) and Acute Myeloid Leukemia Research (21 papers). The work is most often cited by research in Genetics (2.5k citations), Pathology and Forensic Medicine (2.2k citations) and Hematology (1.4k citations). Ricardo Morilla has collaborated with scholars based in United Kingdom, Spain and Switzerland. Frequent co-authors include Estella Matutes, Daniel Catovsky, K Owusu-Ankomah, D Catovsky, Nahla Farahat, E Matutes, John Swansbury, Massimo De Martinis, Lia Ginaldi and Alison Morilla. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.